UK markets close in 6 hours 59 minutes

GRFS Jun 2024 6.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
1.50000.0000 (0.00%)
As of 11:42AM EDT. Market open.
Full screen
Previous close1.5000
Open1.5000
Bid0.0000
Ask1.4000
Strike6.00
Expiry date2024-06-21
Day's range1.5000 - 1.5000
Contract rangeN/A
Volume12
Open interest42
  • GlobeNewswire

    Grifols’ Biotest receives FDA approval for innovative Yimmugo® immunoglobulin to treat primary immunodeficiencies

    With Biotest-developed Yimmugo, Grifols adds to its remarkable franchise of intravenous and subcutaneous immunoglobulins to meet strong demand Yimmugo, already approved for production and marketing in Europe, is the first U.S.-approved medicine in Biotest’s portfolio and is manufactured with an innovative process at Biotest’s new FDA-certified ‘Next Level’ facility U.S. approval of Yimmugo paves the way for other Biotest proteins in late-stage development, including fibrinogen and trimodulin Lau

  • PR Newswire

    Grifols 2023 Annual Report on Form 20-F filed with the SEC

    Grifols, S.A. ("Grifols") (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, today announces the filing of its Annual Report on Form 20-F for the fiscal year ended December 31, 2023, with the United States Securities and Exchange Commission ("SEC").

  • Globe Newswire

    Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.

    The addition of the Clayton site in 2011 marked a new milestone for Grifols, turning the company into a top-three plasma industry leader and setting the stage for sustained business growth The flagship Grifols campus is a touchstone of Grifols’ leadership in plasma therapeutics, producing about 40% of the company’s total medicinal output globally and helping enhance the quality of life of patients all over the worldAn engineering masterwork, the Clayton site is a model for new Grifols plants whi